News
Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare diseases, and ...
From hydration status to physical activity and muscle mass, here is a list of daily habits that can fuel or ruin the overall ...
Eli Lilly's Mounjaro helped children and adolescents aged 10 to 17 years with type 2 diabetes manage their blood sugar better ...
Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...
Heart attacks are caused by the sudden occlusion of any of the 3 coronary arteries or their branches supplying blood to the ...
BASF, Arkema, and AkzoNobel have reduced the carbon footprint of AkzoNobel’s Interpon D superdurable architectural powder coatings by up to 40% ...
Ultimately, in consultation with her oncologist, Katie selected ALUNBRIG ® (brigatinib) as her first-line treatment option, ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for the District of Delaware against ...
The indication for the chemotherapy-containing system stipulates use in adults with bacillus Calmette-Guerin (BCG)-unresponsive NMIBC with carcinoma in situ -- with or without papillary tumors -- and ...
Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved INLEXZO™ (gemcitabine intravesical system), a new, potentially practice-changing approach for treating ...
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:50 PM EDT ...
First and only drug releasing system to provide extended local delivery of a cancer medication into the bladder, with 82 percent of patients achieving complete response without the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results